IVANO BIOSCIENCE

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jan 2025 filing date already counts against anyone who files later.

Record

Serial number

99022612

Mark type

Stylized text

Filed

29 Jan 2025

Published for opposition

24 Feb 2026

Attorney of record

Adelina E. Simpson

Goods and services

• Class 001 — Chemicals: Biological assays for research purposes in the fields of biological and diagnostic testing; kits comprised of biological assays and reagents for research purposes in the fields of biological and diagnostic testing; laboratory assay kits comprised of assays and reagents for research purposes; single-cell organisms for research use; Chemical diagnostic reagents for industrial use, namely, for use in biomanufacturing processes; genetically modified cells for research use; genome editing reagents for research use; viral vectors for research use; protein in raw material form for scientific and medical research; peptide substrates for scientific research purposes; diagnostic preparations in the nature of peptide substrates, other than for medical or veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes, namely, aptamers for research use; media for single-cell organism culture for research use
• Class 005 — Pharmaceuticals: Medical diagnostic reagents and assays for testing of body fluids; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; genetically modified cells for medical use, namely, diagnostic and therapeutic use; genome editing reagents for medical use, namely, diagnostic and therapeutic use; protein arrays for medical diagnosis purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; synthetic peptides for the treatment of cancer, genetic disorders, viral and infectious diseases; nucleic acid sequences for medical and veterinary purposes, namely, aptamers for diagnostic and therapeutic use; media for single-cell organism culture for medical use; single-cell organisms for medical use, namely, diagnostic and therapeutic use
• Class 042 — Scientific and technological services: Custom design and development of chemical reagents and biochemical assays; research and development in the fields of assays, biological selection, medical screening, medical diagnostic testing, medical diagnostic imaging, and medical diagnostics using biomimicry technology; biochemical analysis; biochemical research; biomedical research services; biomedical research services, namely, preparation of biological samples for testing and analysis in research laboratories; research and development in the medical biotechnology field

Owner

• AB VALIDATION INC., Québec, Québec, CA
• AB VALIDATION INC., Québec, Québec, CA

Prosecution history

• 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Feb 2026 — PUBLISHED FOR OPPOSITION
• 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 02 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 28 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 28 Jan 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 28 Jan 2026 — USE AMENDMENT ACCEPTED
• 27 Jan 2026 — AMENDMENT TO USE PROCESSING COMPLETE
• 27 Jan 2026 — USE AMENDMENT FILED
• 27 Jan 2026 — TEAS AMENDMENT OF USE RECEIVED
• 22 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 22 Oct 2025 — LETTER OF SUSPENSION E-MAILED
• 22 Oct 2025 — SUSPENSION LETTER WRITTEN
• 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED